Search research articles
Contact Us
Filters
Showing results (211-220 of 279) with videos related to
Page
of 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2009
Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings
Lisa Diller, Eric J Chow, James G Gurney, et al.
Acta Neuropathologica
|
February 11, 2012
A prognostic gene expression signature in infratentorial ependymoma
Khalida Wani, Terri S Armstrong, Elizabeth Vera-Bolanos, et al.
Neuro-Oncology
|
December 26, 2023
Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group
Sabine Mueller, Jason Fangusaro, Arzu Onar Thomas, et al.
Journal of Neuro-Oncology
|
May 28, 2025
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104
Vihang Nakhate, Ina Ly, Alona Muzikansky, et al.
Neuro-Oncology
|
January 1, 2017
Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study
Allison A King, Kristy Seidel, Chongzhi Di, et al.
Pediatric Blood & Cancer
|
April 23, 2014
Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas
Brigitte C Widemann, Dusica Babovic-Vuksanovic, Eva Dombi, et al.
Acta Neuropathologica
|
August 13, 2015
A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation
Cheng-Ying Ho, Bret C Mobley, Heather Gordish-Dressman, et al.
Neuro-Oncology
|
April 5, 2012
Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis
Michael J Fisher, Michael Loguidice, David H Gutmann, et al.
The New England Journal of Medicine
|
September 21, 2023
Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 Mutations
Eric Bouffet, Jordan R Hansford, Maria Luisa Garrè, et al.
Cancer
|
October 10, 2013
Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022)
Jason Fangusaro, Sridharan Gururangan, Tina Young Poussaint, et al.
Page
of 28
Search research articles
Search
Showing results (211-220 of 279) with videos related to
Sort By:
Page
of 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2009
Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings
Lisa Diller, Eric J Chow, James G Gurney, et al.
Acta Neuropathologica
|
February 11, 2012
A prognostic gene expression signature in infratentorial ependymoma
Khalida Wani, Terri S Armstrong, Elizabeth Vera-Bolanos, et al.
Neuro-Oncology
|
December 26, 2023
Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group
Sabine Mueller, Jason Fangusaro, Arzu Onar Thomas, et al.
Journal of Neuro-Oncology
|
May 28, 2025
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104
Vihang Nakhate, Ina Ly, Alona Muzikansky, et al.
Neuro-Oncology
|
January 1, 2017
Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study
Allison A King, Kristy Seidel, Chongzhi Di, et al.
Pediatric Blood & Cancer
|
April 23, 2014
Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas
Brigitte C Widemann, Dusica Babovic-Vuksanovic, Eva Dombi, et al.
Acta Neuropathologica
|
August 13, 2015
A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation
Cheng-Ying Ho, Bret C Mobley, Heather Gordish-Dressman, et al.
Neuro-Oncology
|
April 5, 2012
Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis
Michael J Fisher, Michael Loguidice, David H Gutmann, et al.
The New England Journal of Medicine
|
September 21, 2023
Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 Mutations
Eric Bouffet, Jordan R Hansford, Maria Luisa Garrè, et al.
Cancer
|
October 10, 2013
Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022)
Jason Fangusaro, Sridharan Gururangan, Tina Young Poussaint, et al.
Page
of 28